FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

422264003: Powder for prolonged-release suspension for injection (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3620912013 Powder for prolonged-release suspension for injection (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3620913015 Powder for prolonged-release suspension for injection en Synonym Active Entire term case insensitive SNOMED CT core module
3620914014 Powder for extended-release suspension for injection en Synonym Active Entire term case insensitive SNOMED CT core module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Powder for prolonged-release suspension for injection Is a Powder for conventional release suspension for injection false Inferred relationship Existential restriction modifier
Powder for prolonged-release suspension for injection Is a Parenteral dose form true Inferred relationship Existential restriction modifier
Powder for prolonged-release suspension for injection Has dose form administration method Inject true Inferred relationship Existential restriction modifier
Powder for prolonged-release suspension for injection Has dose form transformation Disperse true Inferred relationship Existential restriction modifier
Powder for prolonged-release suspension for injection Has dose form intended site Parenteral true Inferred relationship Existential restriction modifier
Powder for prolonged-release suspension for injection Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Powder for prolonged-release suspension for injection Has basic dose form Powder true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lyophilized powder for prolonged-release suspension for injection Is a True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely risperidone 25 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely risperidone 37.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely risperidone 50 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely leuprorelin acetate 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely leuprorelin acetate 11.25 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely leuprorelin acetate 30 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely exenatide 2 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely olanzapine (as olanzapine embonate) 405 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely olanzapine (as olanzapine embonate) 300 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely olanzapine (as olanzapine embonate) 210 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) Has manufactured dose form True Powder for prolonged-release suspension for injection Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start